Find Sodium Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

225 RELATED EXCIPIENT COMPANIES

357EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 7757-82-6, Disodium sulfate, Sodium sulfate, anhydrous, Sodium sulfate anhydrous, Sodium sulphate, Salt cake
Molecular Formula
Na2O4S
Molecular Weight
142.04  g/mol
InChI Key
PMZURENOXWZQFD-UHFFFAOYSA-L
FDA UNII
36KCS0R750

Sodium Sulfate
Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions.
1 2D Structure

Sodium Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
disodium;sulfate
2.1.2 InChI
InChI=1S/2Na.H2O4S/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2
2.1.3 InChI Key
PMZURENOXWZQFD-UHFFFAOYSA-L
2.1.4 Canonical SMILES
[O-]S(=O)(=O)[O-].[Na+].[Na+]
2.2 Other Identifiers
2.2.1 UNII
36KCS0R750
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Disodium Sulfate

2. Mangxiao

3. Mirabilitum

4. Natrii Sulphas

5. Puxiao

6. Sodium Bisulfate

7. Sodium Bisulfate, Monohydrate

8. Sodium Hydrosulfate

9. Sodium Sulfate, 35s-labeled Cpd

10. Sodium Sulfate, Decahydrate

11. Sulfuric Acid, Monosodium Salt

12. Thenardite

2.3.2 Depositor-Supplied Synonyms

1. 7757-82-6

2. Disodium Sulfate

3. Sodium Sulfate, Anhydrous

4. Sodium Sulfate Anhydrous

5. Sodium Sulphate

6. Salt Cake

7. Sodiumsulfate

8. Sulfuric Acid Disodium Salt

9. Disodium Sulphate

10. Disodium;sulfate

11. 15124-09-1

12. Sulfuric Acid, Sodium Salt

13. Sulfate, Sodium

14. Sodium Sulphate Anhydrous

15. Sodium Sulfate, Dried [jan]

16. Sodium Sulfate, Dried

17. Na2so4

18. Mfcd00003504

19. Sodium Sulphate, Anhydrous

20. Chebi:32149

21. 36kcs0r750

22. Nsc-403914

23. Sulfuric Acid, Mono-c14-18-alkyl Esters, Sodium Salts

24. 13759-07-4

25. Sodium Sulfate, Dried (jan)

26. Dibasic Sodium Sulfate

27. Natriumsulfat (german)

28. Na Sulphate

29. Caswell No. 793

30. Hsdb 5042

31. Sodium Sulfate Anyhdrous

32. Sulfuric Acid Sodium Salt (1:2)

33. Sodium Sulfate (solution)

34. Thenardite (na2(so4))

35. Natriumsulfat

36. Sodium Tallow Alcohol Sulfate

37. Unii-36kcs0r750

38. Einecs 231-820-9

39. Einecs 268-366-6

40. Einecs 268-773-9

41. Einecs 270-211-2

42. Epa Pesticide Chemical Code 005604

43. Nsc 403914

44. Sodium Sulfate Acs He

45. Ai3-02398

46. Sda 17-062-04

47. Sulfuric Acid Sodium Salt

48. Dsstox_cid_1291

49. Ec 231-820-9

50. Dsstox_rid_76063

51. Sodium Sulfate [mi]

52. Dsstox_gsid_21291

53. Sodium Sulfate, Acs Reagent

54. Sodium Sulfate, Dried (tn)

55. Sodium Sulfate [hsdb]

56. Chembl233406

57. Dtxsid1021291

58. Anhydous Sodium Sulfate (jp17)

59. Sodium Sulfate - Drilling Grade

60. Bcp13313

61. Sodium Sulfate, For Residue Analysis

62. Tox21_201045

63. Sodium Sulfate Anhydrous [ii]

64. Akos015833463

65. Anhydrous Sodium Sulfate [jan]

66. Sodium Sulfate Anhydrous Granular Acs

67. Sodium Sulfate, Bioxtra, >=99.0%

68. Sulfuric Acid Disodium Salt, Anhydrous

69. Db09472

70. Anhydrous Sodium Sulfate [mart.]

71. Ncgc00258598-01

72. Sodium Sulfate, Lr, Anhydrous, >=99%

73. E514

74. Sodium Sulfate Anhydrous [usp-rs]

75. Sodium Sulfate Anhydrous [who-dd]

76. Sodium Sulfate Anhydrous; Sodium Sulphate

77. Cas-7757-82-6

78. Sodium Sulfate, Anhydrous [who-ip]

79. Sodium Sulfate, Ar, Anhydrous, >=99.5%

80. Ft-0645112

81. S0566

82. Sodium Sulfate, 99.9955% (metals Basis)

83. Sodium Sulfate, Reagentplus(r), >=99.0%

84. Sodium Sulfate Anhydrous [orange Book]

85. Sodium Sulfate, For Pesticide Residue Analysis

86. Sodium Sulfate, Trace Metals Grade, 99.99%

87. D01732

88. Natrii Sulfas Anhydricus [who-ip Latin]

89. Sodium Sulfate, >=99.99% Trace Metals Basis

90. Sodium Sulfate, Jis Special Grade, >=99.0%

91. Sodium Sulfate, Vetec(tm) Reagent Grade, 99%

92. Sodium Sulfate Anhydrous [usp Monograph]

93. Sodium Sulfate, Anhydrous [ep Monograph]

94. Sodium Sulfate, Meets Usp Testing Specifications

95. Q211737

96. Sodium Sulfate, For Hplc, 99.0-101.0% (t)

97. Sodium Sulfate, Purum, Anhydrous, >=99.0% (t)

98. Sodium Sulfate, Saj First Grade, >=99.0%, Beads

99. Sodium Sulfate, Saj First Grade, >=99.0%, Powder

100. Sodium Sulfate, >=99.0%, Plant Cell Culture Tested

101. Sodium Sulfate, Bioultra, Anhydrous, >=99.0% (t)

102. Sodium Sulfate, P.a., 99.0-101.0%, Reag. Iso

103. Sodium Sulfate, For Pesticide Residue Analysis, 99.0%

104. Sodium Sulfate, Tested According To Ph.eur., Anhydrous

105. Sulfuric Acid Disodium Salt, Anhydrous [who-ip]

106. Sodium Sulfate, Acs Reagent, >=99.0%, Anhydrous, Powder

107. Sodium Sulfate, Acs Reagent, >=99.0%, Anhydrous, Granular

108. Sodium Sulfate, Anhydrous, Free-flowing, Redi-dri(tm), Acs Reagent, >=99%

109. Sodium Sulfate Anhydrous, United States Pharmacopeia (usp) Reference Standard

110. Sodium Sulfate, Anhydrous, Free-flowing, Redi-dri(tm), Reagentplus(r), >=99%

111. Sodium Sulfate, Anhydrous, Granular, Free-flowing, Redi-dri(tm), Acs Reagent, >=99%

112. Sodium Sulfate, Puriss. P.a., Acs Reagent, Reag. Iso, Reag. Ph. Eur., Anhydrous, >=99.0%

113. Sodium Sulfate, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Usp, Anhydrous, 99.0-100.5% (calc. To The Dried Substance)

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 142.04 g/mol
Molecular Formula Na2O4S
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count0
Exact Mass141.93126821 g/mol
Monoisotopic Mass141.93126821 g/mol
Topological Polar Surface Area88.6 Ų
Heavy Atom Count7
Formal Charge0
Complexity62.2
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Therapeutic Uses

Cathartics

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


EXPL THER /The purpose of the study was/ to evaluate the early bone response to a nanotextured dental implant treated with sodium sulfate (Na2SO4), using a rabbit model. Twelve animals were randomly divided into group 1 (Control) - machined implants and group 2 (Test) - nanotextured implants. Extra-oral incision was performed to provide access to intended surgical site where the dental implant was inserted immediately after the extraction of the mandibular first premolar. Implant surface characterization was performed by scanning electron microscopy attached to energy dispersive spectroscopy and interferometry. Three weeks after surgery, the animals were induced to death and undecalcified sections of the samples were prepared for histological and histomorphometrical analysis. Surface characterization of the implant demonstrated enhanced surface area of anodized group compared to Control group with 19.2% +/- 6.2 versus 1.6 +/- 0.7, respectively. Histological evaluation demonstrated new bone formation starting from the buccal and lingual cortical walls on both groups. After three weeks, significant higher bone contact of 27% (p<0.05) was observed to nanotextured compared to machined implants (Control group). The anodization with sodium sulfate nanostructures to the implant surface that resulted in faster osseointegration.

PMID:24919046 Pinheiro FA et al; Acta Cir Bras 29 (6): 376-82 (2014)


/EXPL THER/ ... 2-16 mmol/kg of sodium sulfate and sulfur-containing amino acids (cysteine or methionine) were infused intravenously for 2 hr into pentobarbital-anesthetized rats. ... Hepatic 3'-phosphoadenosine 5'-phosphosulfate concentrations increased significantly (30-35%) only when infused with the higher doses (8 or 16 mmol/kg/2 hr) of sodium sulfate.

PMID:7493551 Kim HJ et al; Drug Metab Dispos 23 (8): 840-5 (1995)


VET: Cathartic

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK: Royal Society of Chemistry, 2013., p. 1607


For more Therapeutic Uses (Complete) data for Sodium sulfate (12 total), please visit the HSDB record page.


4.2 Drug Warning

Sodium sulfate used in treatment of hypercalcemia may result in hypokalemia and hypernatremia. Thus, the progress of patients with cardiovascular disease should be watched closely when ... infusions are administered.

Hansten, P.D. Drug Interactions. 4th ed. Philadelphia: Lea and Febiger, 1979., p. 396


4.3 Drug Indication

indicated for bowel cleansing prior to colonoscopy or barium enema X-ray examination.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Induces catharsis by the osmotic effects of the unabsorbed sulfate salts and polyethylene glycol (PEG) in the GI tract. Specifically, sulfate salts provide sulfate anions, which are poorly absorbed, and PEG, which is primarily unabsorbed, causes water to be retained in the GI tract resulting in watery diarrhea.


5.2 MeSH Pharmacological Classification

Cathartics

Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)


5.3 FDA Pharmacological Classification
5.3.1 Pharmacological Classes
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Increased Large Intestinal Motility [PE]
5.4 ATC Code

A - Alimentary tract and metabolism

A06 - Drugs for constipation

A06A - Drugs for constipation

A06AD - Osmotically acting laxatives

A06AD13 - Sodium sulfate


A - Alimentary tract and metabolism

A12 - Mineral supplements

A12C - Other mineral supplements

A12CA - Sodium

A12CA02 - Sodium sulfate


5.5 Absorption, Distribution and Excretion

Absorption

Absorption of sodium sulfate after ingestion in rats was investigated. 35)S-Radioactivity excreted in urine during 24 hr indicated almost complete absorption from GI tract. Determination in serum 2 hr after admin revealed 3-fold increase in sulfate concentration rapid and almost complete absorption of inorganic sulfate occurs after oral admin in rats.


Route of Elimination

Rectal effluent if unabsorbed sulfates ; urine (predominant route for absorbed sulfates )


The importance of tissue sulfate concentrations in regulating 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthesis is not known. Therefore, this study was conducted to determine the influence of increased availability of inorganic sulfate on steady-state PAPS concentrations in various tissues. To increase tissue sulfate concentrations, 2-16 mmol/kg of sodium sulfate and sulfur-containing amino acids (cysteine or methionine) were infused intravenously for 2 hr into pentobarbital-anesthetized rats. Serial blood samples were taken during the infusion and analyzed for sulfate concentrations. After 2 hr of infusion, liver, kidney, and brain were removed for quantification of tissue PAPS and sulfate concentrations. Infusion of sodium sulfate, cysteine, and methionine increased serum and tissue sulfate concentrations in a dose- and time-dependent manner. Serum sulfate concentrations increased from 0.8 to 14 mM during the infusion of sodium sulfate, whereas infusions of cysteine and methionine increased serum sulfate concentrations to 4.8 and 2.0 mM, respectively. Tissue sulfate concentrations also increased during sulfate infusion. Liver sulfate concentration increased from 0.8 to 4.8 mM, kidney concentration increased from 0.6 to 31 mM, and brain concentration increased from 0.1 to 0.6 mM. Similar to the serum sulfate concentrations, sulfate infusion was the most effective in increasing tissue sulfate concentrations, cysteine was intermediate, and methionine the least effective. Although sulfate concentrations in liver, kidney, and brain increased 6-, 50-, and 6-fold by infusing sulfate, respectively; tissue PAPS levels were not altered markedly. Hepatic PAPS concentrations increased significantly (30-35%) only when infused with the higher doses (8 or 16 mmol/kg/2 hr) of sodium sulfate.

PMID:7493551 Kim HJ et al; Drug Metab Dispos 23 (8): 840-5 (1995)


The absorption of inorganic sulfate after ingestion was investigated in rats. After oral administration of Na235SO4, 35S radioactivity was measurable in plasma already after 15 min and its plasma concentration reached a peak after about 1.5-2 hr. The 35S-radioactivity excreted in urine during 24 hr after ingestion of Na235SO4 together with varying amounts of unlabelled Na2SO4 (0.25-5.0 mmol Na2SO4 per rat) indicated an almost complete absorption of inorganic sulfate from the gastrointestinal tract. Determination of the inorganic sulfate concentration in rat serum 2 hr after oral administration of 5.0 mmol Na2SO4 revealed a three-fold increase in serum sulfate concentration. The data suggest a rapid and almost complete absorption of inorganic sulfate after oral administration in the rat. Its importance in relation to the sulfate availability for sulfate conjugation of drugs is discussed.

PMID:476150 Krijgsheld KR et al; Biochim Biophys Acta 586 (3): 492-500 (1979)


Sodium sulfate can be used to enhance the conjugation of phenolic drugs with sulfate and to treat hypercalcemia. It is thought that sulfate in is absorbed slowly and incompletely from the digestive tract. The purposes of this investigation were to determine the absorption of large amount of sodium sulfate(18.1 g as the decahydrate, equivalent to 8.0 g of the anhydrous salt) and to compare the bioavailability when this amount is administered orally to normal subjects as a single dose and as four equally divided hourly doses. The 72-hr urinary recovery of free sulfate following single and divided doses was 53.4 +/- 15.8 and 61.8 +/- 7.8%, respectively (mean +/- SD, n=5, p > 0.2). The single dose produced severe diarrhea while the divided doses caused only mild or no diarrhea. Thus, a large amount of sodium sulfate, when administered orally in divided doses over 3 hr, is well tolerated and is absorbed to a significant extent. Orally administered sodium sulfate may be useful for the early treatment of acetaminophen overdose.

PMID:7264905 Cocchetto DM, Levy G; J Pharm Sci 70 (3): 331-3 (1981)


The renal excretion of potassium by unanesthetized sheep was studied in clearance studies in which water and sodium excretion were elevated by intravenous infusion of isotonic sodium chloride, hypertonic sodium phosphate, or hypertonic sodium sulfate. Aldosterone was infused at 10 ug/hr in some experiments with sodium sulfate. Sodium excretion increased in all experiments, rising at times to equal 25% of the filtered load. Urine flow increased in most experiments. Glomerular filtration rate increased only with infusion of isotonic saline. No consistent change in potassium excretion occurred under any of these loading conditions. This finding contrasts with the increase in potassium excretion commonly seen in man, dogs, and rats intravenously loaded with sodium salts.

PMID:645906 Rabinowitz L, Gunther RA; Am J Physiol 234 (5): F371-5 (1978)


5.6 Biological Half-Life

Serum sulfate: 8.5 hours


5.7 Mechanism of Action

MoviPrep produces a watery stool leading to cleansing of the colon. The osmotic activity of polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid, when taken with 1 liter of additional clear fluid, usually results in no net absorption or excretion of ions or water.


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663439400,"product":"EQUILIN SODIUM SULFATE (SAMPLE FOR RESEARCH AND ANALYSIS, FOC )","address":"SURVEY NO.225, SAMPANBOLE VILLAGE, SHAMIRPET MANDAL","city":"MEDCHAL-MALKAKGIRI DISTRICT,TELANGA","supplier":"ASPEN API","supplierCountry":"NETHERLANDS","foreign_port":"NA","customer":"ALPHAMED FORMULATIONS PRIVATE ","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"5","unit":"GMS","unitRateFc":"20","totalValueFC":"100.8","currency":"EUR","unitRateINR":"1616","date":"18-Sep-2022","totalValueINR":"8080","totalValueInUsd":"100.8","indian_port":"HYDERABAD AIR","hs_no":"29372300","bill_no":"2496310","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"SURVEY NO.225, SAMPANBOLE VILLAGE, SHAMIRPET MANDAL"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705429800,"product":"17 ALPHA ESTRADIOL SODIUM SULFATE (SAMPLE FOR RESEARCH AND ANALYSIS, FOC )","address":"ASURVEY NO.225, SAMPANBOLE VILLAGE","city":"","supplier":"ASPEN API","supplierCountry":"NETHERLANDS","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"ALPHAMED FORMULATIONS PRIVATE ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"3","unit":"GMS","unitRateFc":"33.3","totalValueFC":"111.5","currency":"EUR","unitRateINR":"3090","date":"17-Jan-2024","totalValueINR":"9270","totalValueInUsd":"111.5","indian_port":"Hyderabad Air","hs_no":"29372300","bill_no":"9695680","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"AMSTERDAM, SCHIPHOL","supplierAddress":"NETHERLANDSSDNFSDNF NL","customerAddress":"ASURVEY NO.225, SAMPANBOLE VILLAGE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705429800,"product":"17 BETA DIHYDROEQUILIN SODIUM SULFATE (SAMPLE FOR RESEARCH AND ANALYSIS, FOC )","address":"ASURVEY NO.225, SAMPANBOLE VILLAGE","city":"","supplier":"ASPEN API","supplierCountry":"NETHERLANDS","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"ALPHAMED FORMULATIONS PRIVATE ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.5","unit":"GMS","unitRateFc":"200","totalValueFC":"111.5","currency":"EUR","unitRateINR":"18540","date":"17-Jan-2024","totalValueINR":"9270","totalValueInUsd":"111.5","indian_port":"Hyderabad Air","hs_no":"29372300","bill_no":"9695680","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"AMSTERDAM, SCHIPHOL","supplierAddress":"NETHERLANDSSDNFSDNF NL","customerAddress":"ASURVEY NO.225, SAMPANBOLE VILLAGE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705429800,"product":"EQUILENIN SODIUM SULFATE (SAMPLE FOR RESEARCH AND ANALYSIS,FOC )","address":"ASURVEY NO.225, SAMPANBOLE VILLAGE","city":"","supplier":"ASPEN API","supplierCountry":"NETHERLANDS","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"ALPHAMED FORMULATIONS PRIVATE ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.5","unit":"GMS","unitRateFc":"200","totalValueFC":"111.5","currency":"EUR","unitRateINR":"18540","date":"17-Jan-2024","totalValueINR":"9270","totalValueInUsd":"111.5","indian_port":"Hyderabad Air","hs_no":"29372300","bill_no":"9695680","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"AMSTERDAM, SCHIPHOL","supplierAddress":"NETHERLANDSSDNFSDNF NL","customerAddress":"ASURVEY NO.225, SAMPANBOLE VILLAGE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705429800,"product":"EQUILIN SODIUM SULFATE (SAMPLE FOR RESEARCH AND ANALYSIS, FOC )","address":"ASURVEY NO.225, SAMPANBOLE VILLAGE","city":"","supplier":"ASPEN API","supplierCountry":"NETHERLANDS","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"ALPHAMED FORMULATIONS PRIVATE ","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"3","unit":"GMS","unitRateFc":"33.3","totalValueFC":"111.5","currency":"EUR","unitRateINR":"3090","date":"17-Jan-2024","totalValueINR":"9270","totalValueInUsd":"111.5","indian_port":"Hyderabad Air","hs_no":"29372300","bill_no":"9695680","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"AMSTERDAM, SCHIPHOL","supplierAddress":"NETHERLANDSSDNFSDNF NL","customerAddress":"ASURVEY NO.225, SAMPANBOLE VILLAGE"}]
18-Sep-2022
17-Jan-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;1...DOSAGE - POWDER;ORAL - 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT

USFDA APPLICATION NUMBER - 204553

read-more

DOSAGE - TABLET;ORAL - 0.225GM;0.188GM;1.479G...DOSAGE - TABLET;ORAL - 0.225GM;0.188GM;1.479GM

USFDA APPLICATION NUMBER - 213135

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Taste Masking

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Coating Systems & Additives

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty